Description: A contraceptive microchip that is implanted under the skin and continuously releases a progestin for as long as 16 years. It is also programmable such that the release of progestin can be turned on and off by the user or provider.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Subdermal

Duration Type: Long-acting

Duration: 16 years

  • Daily release

Dose: 30 mcg

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: Microchips Biotech, Inc.

Project Phase: Discovery and Early Development

Development Stage: Prototype Development

Began discovery in: 2013

Active Development: Yes

Status Details:
  • Microchips is also developing their technology for other therapeutic areas.

Additional Information


Vertical Tabs